<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title /><description /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Pharmatech" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="pharmatech" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item><guid isPermaLink="false">28</guid><link>http://pharmatechoncology.com/sponsors/media/press-releases/sbir-phase-I-completion/</link><title>Pharmatech Oncology Announces Completion of SBIR Grant Research</title><description /><a10:updated>2011-10-19T23:19:26-06:00</a10:updated></item><item><guid isPermaLink="false">27</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20101011/</link><title>Pharmatech Oncology Announces ASH Abstract</title><a10:updated>2010-10-11T00:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">26</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20100706/</link><title>Press Release from Tamir Biotechnologies</title><a10:updated>2010-07-06T00:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">25</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20100625/</link><title>Pharmatech Oncology's Presentation at 46th Annual DIA Meeting</title><a10:updated>2010-06-25T00:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">24</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20100610/</link><title>Pharmatech Oncology to Present at 46th Annual DIA Meeting</title><a10:updated>2010-06-10T15:30:00-06:00</a10:updated></item><item><guid isPermaLink="false">23</guid><link>http://www.arideagainstlymphoma.blogspot.com/</link><title>A Ride Against Lymphoma</title><a10:updated>2010-05-26T15:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">22</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20100517/</link><title>Pharmatech Oncology Announces ASCO Abstracts</title><a10:updated>2010-05-17T08:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">21</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20090423/</link><title>Pharmatech Oncology Launches New Data Management Business Unit</title><a10:updated>2009-04-23T09:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">20</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20090407/</link><title>Pharmatech Oncology Selected to Present at Company Showcase at Biozona</title><a10:updated>2009-04-07T09:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">19</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20090318/</link><title>The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor</title><a10:updated>2009-03-19T09:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">18</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20081230/</link><title>Pharmatech 2.0: Introducing Pharmatech Oncology</title><a10:updated>2009-01-05T08:00:00-07:00</a10:updated></item><item><guid isPermaLink="false">17</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20080930/</link><title>Matthew B. Wiener Wins Outstanding Researcher Award</title><a10:updated>2008-10-01T08:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">16</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20080724/</link><title>Pharmatech Contracts for Five New Just-In-Time Trials</title><a10:updated>2008-07-24T08:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">13</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20080303/</link><title>Pharmatech Teams up with Systems Medicine LLC and The Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial</title><a10:updated>2008-03-03T08:00:00-07:00</a10:updated></item><item><guid isPermaLink="false">11</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20071204/</link><title>Pharmatech Presents Preliminary Trial Results at 49th Annual ASH Meeting</title><a10:updated>2007-12-04T08:00:00-07:00</a10:updated></item><item><guid isPermaLink="false">10</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20071107/</link><title>Pharmatech Inc. Wins Award</title><a10:updated>2007-11-07T08:00:00-07:00</a10:updated></item><item><guid isPermaLink="false">7</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20070702/</link><title>OmniComm, Inc. Partnership</title><a10:updated>2007-06-05T08:00:00-06:00</a10:updated></item><item><guid isPermaLink="false">2</guid><link>http://www.pharmatechoncology.com/sponsors/media/press-releases/20060216/</link><title>Pharmatech Reports Business Results From 2005; Details Network Model For Growth In 2006</title><a10:updated>2006-02-16T08:00:00-07:00</a10:updated></item></channel></rss>

